Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.09M Sell
3,111
-37
-1% -$13.2K 0.3% 57
2025
Q4
$1.03M Hold
3,148
0.31% 51
2025
Q3
$889K Sell
3,148
-15
-0.5% -$4.35K 0.29% 60
2025
Q2
$883K Buy
3,163
+14
+0.4% +$3.97K 0.34% 59
2025
Q1
$981K Sell
3,149
-70
-2% -$20.7K 0.42% 49
2024
Q4
$839K Sell
3,219
-19
-0.6% -$5.64K 0.39% 56
2024
Q3
$1.04M Buy
3,238
+10
+0.3% +$3.27K 0.5% 46
2024
Q2
$1.01M Sell
3,228
-211
-6% -$62K 0.54% 39
2024
Q1
$978K Buy
3,439
+48
+1% +$14K 0.58% 38
2023
Q4
$977K Buy
3,391
+12
+0.4% +$3.27K 0.61% 32
2023
Q3
$908K Buy
3,379
+1
+0% +$250 0.61% 33
2023
Q2
$750K Buy
3,378
+375
+12% +$87K 0.49% 42
2023
Q1
$726K Sell
3,003
-75
-2% -$18.4K 0.59% 40
2022
Q4
$903K Buy
3,078
+111
+4% +$29.8K 0.56% 36
2022
Q3
$669K Buy
2,967
+212
+8% +$51.4K 0.44% 48
2022
Q2
$670K Buy
2,755
+450
+20% +$110K 0.39% 54
2022
Q1
$557K Buy
2,305
+310
+16% +$71.2K 0.28% 71
2021
Q4
$449K Buy
+1,995
New +$421K 0.23% 73

Other funds holding AMGN

COWA LLC's AMGN Position: Q1 2026 in Review

COWA LLC reduced its Amgen (AMGN) stake by 1.2% in Q1 2026, selling an estimated $13.2K and leaving 3,111 shares worth $1.09M. The position accounts for 0.3% of the portfolio, ranked #57.

COWA LLC first reported a position in AMGN in Q4 2021 and has held it in 18 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • COWA LLC held 3,111 shares of Amgen worth $1.09M as of Q1 2026.
  • COWA LLC sold 37 Amgen shares in Q1 2026, an estimated $13.2K.
  • Amgen made up 0.3% of COWA LLC's portfolio in Q1 2026, its #57 holding.
  • COWA LLC first reported a position in Amgen in Q4 2021 and has held it in 18 quarters since.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on COWA LLC's 13F filing for Q1 2026, filed 14 May 2026.